PROFUND ADVISORS LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1129919 BETHESDA, MD

Position in RXRX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,134,385

-$82,529 QoQ

Shares Held

309,097

-22.0% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#67

of 344 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $165,155,882 across 170 Biotechnology names. RXRX ranks #57 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	TWST	Twist Bioscience Corp	21,095	$2,170,253
8	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,134,385	309,097	-22.0%	Shares	Sole	2026-08-11
2026-03-31	$1,216,914	396,389	+11.1%	Shares	Sole	2026-04-27
2025-12-31	$1,458,747	356,662	+120.9%	Shares	Sole	2026-02-06
2025-09-30	$787,900	161,455	+109.6%	Shares	Sole	2025-11-06
2025-06-30	$389,751	77,026	-37.4%	Shares	Sole	2025-08-07
2025-03-31	$651,325	123,124	+7.2%	Shares	Sole	2025-05-08
2024-12-31	$776,629	114,886	-13.5%	Shares	Sole	2025-02-14
2024-09-30	$875,224	132,811	+77.6%	Shares	Sole	2024-11-14
2024-06-30	$560,782	74,771	-41.2%	Shares	Sole	2024-08-13
2024-03-31	$1,267,745	127,156	-21.8%	Shares	Sole	2024-05-08
2023-12-31	$1,603,482	162,625	-11.7%	Shares	Sole	2024-02-14
2023-09-30	$1,409,397	184,235	+209.0%	Shares	Sole	2023-11-13
2023-06-30	$445,316	59,614	-16.3%	Shares	Sole	2023-08-10
2023-03-31	$475,064	71,224	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.